Please wait while the formulary information is being retrieved.
Drug overview for CALAGESIC (pramoxine hcl/calamine):
Generic name: pramoxine HCl/calamine (pram-OX-een)
Drug class: Topical Local Anesthetics
Therapeutic class: Dermatological
Pramoxine is a local anesthetic.
Pramoxine preparations are used for self-medication for the temporary relief of pain and itching associated with minor lip or skin irritations (e.g., dermatoses, insect bites, minor burns or sunburns, minor cuts or scrapes, cold sores, rashes due to poison ivy, poison oak, or poison sumac). Pramoxine preparations also are used for self-medication for the temporary relief of pain, soreness, burning, itching, or discomfort associated with hemorrhoids or other anorectal/anogenital disorders (e.g., inflammation, irritation, fissures, anogenital pruritus).
Generic name: pramoxine HCl/calamine (pram-OX-een)
Drug class: Topical Local Anesthetics
Therapeutic class: Dermatological
Pramoxine is a local anesthetic.
Pramoxine preparations are used for self-medication for the temporary relief of pain and itching associated with minor lip or skin irritations (e.g., dermatoses, insect bites, minor burns or sunburns, minor cuts or scrapes, cold sores, rashes due to poison ivy, poison oak, or poison sumac). Pramoxine preparations also are used for self-medication for the temporary relief of pain, soreness, burning, itching, or discomfort associated with hemorrhoids or other anorectal/anogenital disorders (e.g., inflammation, irritation, fissures, anogenital pruritus).
DRUG IMAGES
CALAGESIC LOTION
The following indications for CALAGESIC (pramoxine hcl/calamine) have been approved by the FDA:
Indications:
Arthropod bite wound
Burns
Hemorrhoids
Proctitis
Pruritus of skin
Rectal pain
Skin irritation
Wound
Professional Synonyms:
Burn injuries
Itchy skin eruption
Proctalgia
Pruritic dermatitis
Rectitis
Tissue injury
Indications:
Arthropod bite wound
Burns
Hemorrhoids
Proctitis
Pruritus of skin
Rectal pain
Skin irritation
Wound
Professional Synonyms:
Burn injuries
Itchy skin eruption
Proctalgia
Pruritic dermatitis
Rectitis
Tissue injury
The following dosing information is available for CALAGESIC (pramoxine hcl/calamine):
For self-medication for the temporary relief of pain and itching associated with lip or skin irritations in adults and children 2 years of age and older, pramoxine hydrochloride 1% gel, lotion, ointment, or solution is applied topically to the affected area up to 3 or 4 times daily. For use in children younger than 2 years of age, a pediatrician should be consulted.
For self-medication for the temporary relief of pain, soreness, burning, itching, or discomfort caused by hemorrhoids or other anorectal disorders in adults and children 12 years of age and older, pramoxine hydrochloride 1% aerosol foam, cream, ointment, or pledget is applied topically to the affected area up to 4 or 5 times daily or after each bowel movement. The manufacturers state that this dosage should not be exceeded unless directed by a clinician. For use in children younger than 12 years of age, a clinician should be consulted.
For self-medication for the management of anogenital pruritus, pramoxine hydrochloride 1% pledget is applied to the external vaginal area up to 3-4 times daily. For use in children younger than 12 years of age, a clinician should be consulted.
For self-medication for the temporary relief of pain, soreness, burning, itching, or discomfort caused by hemorrhoids or other anorectal disorders in adults and children 12 years of age and older, pramoxine hydrochloride 1% aerosol foam, cream, ointment, or pledget is applied topically to the affected area up to 4 or 5 times daily or after each bowel movement. The manufacturers state that this dosage should not be exceeded unless directed by a clinician. For use in children younger than 12 years of age, a clinician should be consulted.
For self-medication for the management of anogenital pruritus, pramoxine hydrochloride 1% pledget is applied to the external vaginal area up to 3-4 times daily. For use in children younger than 12 years of age, a clinician should be consulted.
Preparations containing pramoxine hydrochloride are applied topically. These preparations may be applied to the lip in the form of an ointment (''lip balm''); to the skin in the form of a gel, lotion, ointment, or solution; to the external vaginal area in the form of pledgets (pads); or to the external anorectal area in the form of an aerosol foam, cream, ointment, or pledgets. The lotion containing pramoxine hydrochloride should be shaken well prior to use.
The aerosol foam should be shaken well and dispersed onto a clean tissue before applying to the affected area. Pledgets should be applied gently by patting or wiping the affected area; pledgets should be used only once and then discarded. Patients receiving pramoxine-containing preparations for the management of hemorrhoids or other anorectal disorders should be advised to cleanse the affected perianal area with mild soap and warm water and rinsing thoroughly whenever practical; the area then should be dried by patting or blotting with toilet tissue or a soft cloth before application of the drug.
The aerosol foam should be shaken well and dispersed onto a clean tissue before applying to the affected area. Pledgets should be applied gently by patting or wiping the affected area; pledgets should be used only once and then discarded. Patients receiving pramoxine-containing preparations for the management of hemorrhoids or other anorectal disorders should be advised to cleanse the affected perianal area with mild soap and warm water and rinsing thoroughly whenever practical; the area then should be dried by patting or blotting with toilet tissue or a soft cloth before application of the drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for CALAGESIC (pramoxine hcl/calamine):
There are 0 contraindications.
There are 1 severe interactions.
These drug interactions can produce serious consequences in most patients. Actions required for severe interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration scheduling, and providing additional patient monitoring. Review the full interaction monograph for more information.
| Drug Interaction | Drug Names |
|---|---|
| Long-acting Bupivacaine/Local Anesthetics SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: Concurrent use of other local anesthetics or use of other local anesthetics within 96 hours following long-acting bupivacaine may result in additive neurologic and cardiovascular effects. Use of articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, and tetracaine may also increase the risk of methemoglobinemia.(1,2) Non-liposomal bupivacaine may impact the pharmacokinetic and/or physicochemical properties of the liposomal formulation when administered in the same syringe or used simultaneously unless the ratio of mg of non-liposomal bupivacaine to mg of bupivacaine liposomal does not exceed 1:2.(1) Local anesthetics other than bupivacaine may trigger the immediate release of bupivacaine from the liposomal formulation when administered together locally.(1) CLINICAL EFFECTS: Concurrent or use of local anesthetics with 96 hours of use of long-acting bupivacaine may result in neurologic and cardiovascular toxicity. Use of articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, and tetracaine may also result in methemoglobinemia.(1,2) Non-liposomal bupivacaine may impact the pharmacokinetic and/or physicochemical properties of the liposomal formulation when administered in the same syringe or used simultaneously unless the ratio of mg of non-liposomal bupivacaine to mg of bupivacaine liposomal does not exceed 1:2.(1) Local anesthetics other than bupivacaine may trigger the immediate release of bupivacaine from the liposomal formulation when administered together locally.(1) PREDISPOSING FACTORS: Use of additional agents that are associated with methemoglobinemia may further increase the risk of methemoglobinemia.(1) Patients who are at increased risk of developing methemoglobinemia include those with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.(1) PATIENT MANAGEMENT: Avoid the use of other local anesthetics within 96 hours following the administration of long-acting bupivacaine. In patients for whom use is required, monitor for neurologic and cardiovascular effects. Also monitor for methemoglobinemia with use of articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, and tetracaine.(1,2) Non-liposomal bupivacaine may be administered in the same syringe as bupivacaine liposomal or injected immediately before bupivacaine liposomal as long as the ratio of mg of non-liposomal bupivacaine to mg of bupivacaine liposomal does not exceed 1:2.(1) Lidocaine may be administered 20 minutes or more prior to bupivacaine. It is unknown if other local anesthetics may be used without compromising the release characteristic of bupivacaine liposomal.(1) DISCUSSION: Concurrent use of other local anesthetics or use of other local anesthetics within 96 hours following long-acting bupivacaine may result in additive neurologic and cardiovascular effects. Use of articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, and tetracaine may also increase the risk of methemoglobinemia.(1,2) Non-liposome bupivacaine may impact the pharmacokinetic and/or physicochemical properties of the liposomal formulation when administered in the same syringe or used simultaneously unless the ratio of mg of non-liposomal bupivacaine to mg of bupivacaine liposomal does not exceed 1:2.(1) Local anesthetics other than bupivacaine may trigger the immediate release of bupivacaine from the liposomal formulation when administered together locally. Lidocaine may be administered 20 minutes or more prior to bupivacaine. It is unknown if other local anesthetics may be used without compromising the release characteristic of bupivacaine liposomal.(1) |
BUPIVACAINE LIPOSOME, EXPAREL, XARACOLL, ZYNRELEF |
There are 0 moderate interactions.
The following contraindication information is available for CALAGESIC (pramoxine hcl/calamine):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 1 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Large open wound |
There are 0 moderate contraindications.
The following adverse reaction information is available for CALAGESIC (pramoxine hcl/calamine):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 16 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Dermatitis due to topical drug |
| Rare/Very Rare |
|---|
|
Acute respiratory failure Anaphylaxis Angioedema Bradycardia Bronchospastic pulmonary disease Cardiac arrhythmia CNS toxicity Cyanosis Eyelid edema Headache disorder Hypotension Methemoglobinemia Respiratory depression Seizure disorder Unconsciousness |
There are 20 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Blanching of skin Edema Erythema Pruritus of skin Skin rash Stinging of skin Urticaria |
| Rare/Very Rare |
|---|
|
Acute cognitive impairment Apprehension Blurred vision Dizziness Drowsy Euphoria Muscle fasciculation Nervousness Sensation of cold Sensation of warmth Tinnitus Tremor Vomiting |
The following precautions are available for CALAGESIC (pramoxine hcl/calamine):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Women who are pregnant should consult a clinician before initiating therapy with pramoxine-containing preparations.
Women who are breast-feeding should consult a clinician before initiating therapy with pramoxine-containing preparations.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for CALAGESIC (pramoxine hcl/calamine):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for CALAGESIC (pramoxine hcl/calamine)'s list of indications:
| Arthropod bite wound | |
| S00.06xA | Insect bite (nonvenomous) of scalp, initial encounter |
| S00.261A | Insect bite (nonvenomous) of right eyelid and periocular area, initial encounter |
| S00.262A | Insect bite (nonvenomous) of left eyelid and periocular area, initial encounter |
| S00.269A | Insect bite (nonvenomous) of unspecified eyelid and periocular area, initial encounter |
| S00.36xA | Insect bite (nonvenomous) of nose, initial encounter |
| S00.461A | Insect bite (nonvenomous) of right ear, initial encounter |
| S00.462A | Insect bite (nonvenomous) of left ear, initial encounter |
| S00.469A | Insect bite (nonvenomous) of unspecified ear, initial encounter |
| S00.561A | Insect bite (nonvenomous) of lip, initial encounter |
| S00.562A | Insect bite (nonvenomous) of oral cavity, initial encounter |
| S00.86xA | Insect bite (nonvenomous) of other part of head, initial encounter |
| S00.96xA | Insect bite (nonvenomous) of unspecified part of head, initial encounter |
| S10.16xA | Insect bite (nonvenomous) of throat, initial encounter |
| S10.86xA | Insect bite of other specified part of neck, initial encounter |
| S10.96xA | Insect bite of unspecified part of neck, initial encounter |
| S20.161A | Insect bite (nonvenomous) of breast, right breast, initial encounter |
| S20.162A | Insect bite (nonvenomous) of breast, left breast, initial encounter |
| S20.169A | Insect bite (nonvenomous) of breast, unspecified breast, initial encounter |
| S20.361A | Insect bite (nonvenomous) of right front wall of thorax, initial encounter |
| S20.362A | Insect bite (nonvenomous) of left front wall of thorax, initial encounter |
| S20.363A | Insect bite (nonvenomous) of bilateral front wall of thorax, initial encounter |
| S20.364A | Insect bite (nonvenomous) of middle front wall of thorax, initial encounter |
| S20.369A | Insect bite (nonvenomous) of unspecified front wall of thorax, initial encounter |
| S20.461A | Insect bite (nonvenomous) of right back wall of thorax, initial encounter |
| S20.462A | Insect bite (nonvenomous) of left back wall of thorax, initial encounter |
| S20.469A | Insect bite (nonvenomous) of unspecified back wall of thorax, initial encounter |
| S20.96xA | Insect bite (nonvenomous) of unspecified parts of thorax, initial encounter |
| S30.860A | Insect bite (nonvenomous) of lower back and pelvis, initial encounter |
| S30.861A | Insect bite (nonvenomous) of abdominal wall, initial encounter |
| S30.862A | Insect bite (nonvenomous) of penis, initial encounter |
| S30.863A | Insect bite (nonvenomous) of scrotum and testes, initial encounter |
| S30.864A | Insect bite (nonvenomous) of vagina and vulva, initial encounter |
| S30.865A | Insect bite (nonvenomous) of unspecified external genital organs, male, initial encounter |
| S30.866A | Insect bite (nonvenomous) of unspecified external genital organs, female, initial encounter |
| S30.867A | Insect bite (nonvenomous) of anus, initial encounter |
| S40.261A | Insect bite (nonvenomous) of right shoulder, initial encounter |
| S40.262A | Insect bite (nonvenomous) of left shoulder, initial encounter |
| S40.269A | Insect bite (nonvenomous) of unspecified shoulder, initial encounter |
| S40.861A | Insect bite (nonvenomous) of right upper arm, initial encounter |
| S40.862A | Insect bite (nonvenomous) of left upper arm, initial encounter |
| S40.869A | Insect bite (nonvenomous) of unspecified upper arm, initial encounter |
| S50.361A | Insect bite (nonvenomous) of right elbow, initial encounter |
| S50.362A | Insect bite (nonvenomous) of left elbow, initial encounter |
| S50.369A | Insect bite (nonvenomous) of unspecified elbow, initial encounter |
| S50.861A | Insect bite (nonvenomous) of right forearm, initial encounter |
| S50.862A | Insect bite (nonvenomous) of left forearm, initial encounter |
| S50.869A | Insect bite (nonvenomous) of unspecified forearm, initial encounter |
| S60.361A | Insect bite (nonvenomous) of right thumb, initial encounter |
| S60.362A | Insect bite (nonvenomous) of left thumb, initial encounter |
| S60.369A | Insect bite (nonvenomous) of unspecified thumb, initial encounter |
| S60.460A | Insect bite (nonvenomous) of right index finger, initial encounter |
| S60.461A | Insect bite (nonvenomous) of left index finger, initial encounter |
| S60.462A | Insect bite (nonvenomous) of right middle finger, initial encounter |
| S60.463A | Insect bite (nonvenomous) of left middle finger, initial encounter |
| S60.464A | Insect bite (nonvenomous) of right ring finger, initial encounter |
| S60.465A | Insect bite (nonvenomous) of left ring finger, initial encounter |
| S60.466A | Insect bite (nonvenomous) of right little finger, initial encounter |
| S60.467A | Insect bite (nonvenomous) of left little finger, initial encounter |
| S60.468A | Insect bite (nonvenomous) of other finger, initial encounter |
| S60.469A | Insect bite (nonvenomous) of unspecified finger, initial encounter |
| S60.561A | Insect bite (nonvenomous) of right hand, initial encounter |
| S60.562A | Insect bite (nonvenomous) of left hand, initial encounter |
| S60.569A | Insect bite (nonvenomous) of unspecified hand, initial encounter |
| S60.861A | Insect bite (nonvenomous) of right wrist, initial encounter |
| S60.862A | Insect bite (nonvenomous) of left wrist, initial encounter |
| S60.869A | Insect bite (nonvenomous) of unspecified wrist, initial encounter |
| S70.261A | Insect bite (nonvenomous), right hip, initial encounter |
| S70.262A | Insect bite (nonvenomous), left hip, initial encounter |
| S70.269A | Insect bite (nonvenomous), unspecified hip, initial encounter |
| S70.361A | Insect bite (nonvenomous), right thigh, initial encounter |
| S70.362A | Insect bite (nonvenomous), left thigh, initial encounter |
| S70.369A | Insect bite (nonvenomous), unspecified thigh, initial encounter |
| S80.261A | Insect bite (nonvenomous), right knee, initial encounter |
| S80.262A | Insect bite (nonvenomous), left knee, initial encounter |
| S80.269A | Insect bite (nonvenomous), unspecified knee, initial encounter |
| S80.861A | Insect bite (nonvenomous), right lower leg, initial encounter |
| S80.862A | Insect bite (nonvenomous), left lower leg, initial encounter |
| S80.869A | Insect bite (nonvenomous), unspecified lower leg, initial encounter |
| S90.461A | Insect bite (nonvenomous), right great toe, initial encounter |
| S90.462A | Insect bite (nonvenomous), left great toe, initial encounter |
| S90.463A | Insect bite (nonvenomous), unspecified great toe, initial encounter |
| S90.464A | Insect bite (nonvenomous), right lesser toe(s), initial encounter |
| S90.465A | Insect bite (nonvenomous), left lesser toe(s), initial encounter |
| S90.466A | Insect bite (nonvenomous), unspecified lesser toe(s), initial encounter |
| S90.561A | Insect bite (nonvenomous), right ankle, initial encounter |
| S90.562A | Insect bite (nonvenomous), left ankle, initial encounter |
| S90.569A | Insect bite (nonvenomous), unspecified ankle, initial encounter |
| S90.861A | Insect bite (nonvenomous), right foot, initial encounter |
| S90.862A | Insect bite (nonvenomous), left foot, initial encounter |
| S90.869A | Insect bite (nonvenomous), unspecified foot, initial encounter |
| Burns | |
| T30.0 | Burn of unspecified body region, unspecified degree |
| Hemorrhoids | |
| K64.0 | First degree hemorrhoids |
| K64.8 | Other hemorrhoids |
| K64.9 | Unspecified hemorrhoids |
| O22.4 | Hemorrhoids in pregnancy |
| O22.40 | Hemorrhoids in pregnancy, unspecified trimester |
| O22.41 | Hemorrhoids in pregnancy, first trimester |
| O22.42 | Hemorrhoids in pregnancy, second trimester |
| O22.43 | Hemorrhoids in pregnancy, third trimester |
| O87.2 | Hemorrhoids in the puerperium |
| Proctitis | |
| K62.7 | Radiation proctitis |
| K62.89 | Other specified diseases of anus and rectum |
| Pruritus of skin | |
| L29.8 | Other pruritus |
| L29.81 | Cholestatic pruritus |
| L29.89 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| Rectal pain | |
| K62.89 | Other specified diseases of anus and rectum |
| Skin irritation | |
| L24 | Irritant contact dermatitis |
| L24.0 | Irritant contact dermatitis due to detergents |
| L24.1 | Irritant contact dermatitis due to oils and greases |
| L24.2 | Irritant contact dermatitis due to solvents |
| L24.3 | Irritant contact dermatitis due to cosmetics |
| L24.4 | Irritant contact dermatitis due to drugs in contact with skin |
| L24.5 | Irritant contact dermatitis due to other chemical products |
| L24.6 | Irritant contact dermatitis due to food in contact with skin |
| L24.7 | Irritant contact dermatitis due to plants, except food |
| L24.8 | Irritant contact dermatitis due to other agents |
| L24.81 | Irritant contact dermatitis due to metals |
| L24.89 | Irritant contact dermatitis due to other agents |
| L24.9 | Irritant contact dermatitis, unspecified cause |
| L24.A | Irritant contact dermatitis due to friction or contact with body fluids |
| L24.A0 | Irritant contact dermatitis due to friction or contact with body fluids, unspecified |
| L24.A1 | Irritant contact dermatitis due to saliva |
| L24.A2 | Irritant contact dermatitis due to fecal, urinary or dual incontinence |
| L24.A9 | Irritant contact dermatitis due friction or contact with other specified body fluids |
| L24.B | Irritant contact dermatitis related to stoma or fistula |
| L24.B0 | Irritant contact dermatitis related to unspecified stoma or fistula |
| L24.B1 | Irritant contact dermatitis related to digestive stoma or fistula |
| L24.B2 | Irritant contact dermatitis related to respiratory stoma or fistula |
| L24.B3 | Irritant contact dermatitis related to fecal or urinary stoma or fistula |
| L25 | Unspecified contact dermatitis |
| L25.0 | Unspecified contact dermatitis due to cosmetics |
| L25.1 | Unspecified contact dermatitis due to drugs in contact with skin |
| L25.2 | Unspecified contact dermatitis due to dyes |
| L25.3 | Unspecified contact dermatitis due to other chemical products |
| L25.4 | Unspecified contact dermatitis due to food in contact with skin |
| L25.5 | Unspecified contact dermatitis due to plants, except food |
| L25.8 | Unspecified contact dermatitis due to other agents |
| L25.9 | Unspecified contact dermatitis, unspecified cause |
| L30.9 | Dermatitis, unspecified |
| R21 | Rash and other nonspecific skin eruption |
| Wound | |
| S00.01 | Abrasion of scalp |
| S00.01xA | Abrasion of scalp, initial encounter |
| S00.211A | Abrasion of right eyelid and periocular area, initial encounter |
| S00.212A | Abrasion of left eyelid and periocular area, initial encounter |
| S00.219A | Abrasion of unspecified eyelid and periocular area, initial encounter |
| S00.31 | Abrasion of nose |
| S00.31xA | Abrasion of nose, initial encounter |
| S00.41 | Abrasion of ear |
| S00.411 | Abrasion of right ear |
| S00.411A | Abrasion of right ear, initial encounter |
| S00.412 | Abrasion of left ear |
| S00.412A | Abrasion of left ear, initial encounter |
| S00.419 | Abrasion of unspecified ear |
| S00.419A | Abrasion of unspecified ear, initial encounter |
| S00.51 | Abrasion of lip and oral cavity |
| S00.511 | Abrasion of lip |
| S00.511A | Abrasion of lip, initial encounter |
| S00.512 | Abrasion of oral cavity |
| S00.512A | Abrasion of oral cavity, initial encounter |
| S00.81 | Abrasion of other part of head |
| S00.81xA | Abrasion of other part of head, initial encounter |
| S00.91 | Abrasion of unspecified part of head |
| S00.91xA | Abrasion of unspecified part of head, initial encounter |
| S10.11 | Abrasion of throat |
| S10.11xA | Abrasion of throat, initial encounter |
| S10.81 | Abrasion of other specified part of neck |
| S10.81xA | Abrasion of other specified part of neck, initial encounter |
| S10.91 | Abrasion of unspecified part of neck |
| S10.91xA | Abrasion of unspecified part of neck, initial encounter |
| S20.11 | Abrasion of breast |
| S20.111 | Abrasion of breast, right breast |
| S20.111A | Abrasion of breast, right breast, initial encounter |
| S20.112 | Abrasion of breast, left breast |
| S20.112A | Abrasion of breast, left breast, initial encounter |
| S20.119 | Abrasion of breast, unspecified breast |
| S20.119A | Abrasion of breast, unspecified breast, initial encounter |
| S20.31 | Abrasion of front wall of thorax |
| S20.311 | Abrasion of right front wall of thorax |
| S20.311A | Abrasion of right front wall of thorax, initial encounter |
| S20.312 | Abrasion of left front wall of thorax |
| S20.312A | Abrasion of left front wall of thorax, initial encounter |
| S20.313 | Abrasion of bilateral front wall of thorax |
| S20.313A | Abrasion of bilateral front wall of thorax, initial encounter |
| S20.314 | Abrasion of middle front wall of thorax |
| S20.314A | Abrasion of middle front wall of thorax, initial encounter |
| S20.319 | Abrasion of unspecified front wall of thorax |
| S20.319A | Abrasion of unspecified front wall of thorax, initial encounter |
| S20.41 | Abrasion of back wall of thorax |
| S20.411 | Abrasion of right back wall of thorax |
| S20.411A | Abrasion of right back wall of thorax, initial encounter |
| S20.412 | Abrasion of left back wall of thorax |
| S20.412A | Abrasion of left back wall of thorax, initial encounter |
| S20.419 | Abrasion of unspecified back wall of thorax |
| S20.419A | Abrasion of unspecified back wall of thorax, initial encounter |
| S20.91 | Abrasion of unspecified parts of thorax |
| S20.91xA | Abrasion of unspecified parts of thorax, initial encounter |
| S30.81 | Abrasion of abdomen, lower back, pelvis and external genitals |
| S30.810 | Abrasion of lower back and pelvis |
| S30.810A | Abrasion of lower back and pelvis, initial encounter |
| S30.811 | Abrasion of abdominal wall |
| S30.811A | Abrasion of abdominal wall, initial encounter |
| S30.812 | Abrasion of penis |
| S30.812A | Abrasion of penis, initial encounter |
| S30.813 | Abrasion of scrotum and testes |
| S30.813A | Abrasion of scrotum and testes, initial encounter |
| S30.814 | Abrasion of vagina and vulva |
| S30.814A | Abrasion of vagina and vulva, initial encounter |
| S30.815 | Abrasion of unspecified external genital organs, male |
| S30.815A | Abrasion of unspecified external genital organs, male, initial encounter |
| S30.816 | Abrasion of unspecified external genital organs, female |
| S30.816A | Abrasion of unspecified external genital organs, female, initial encounter |
| S30.817 | Abrasion of anus |
| S30.817A | Abrasion of anus, initial encounter |
| S40.21 | Abrasion of shoulder |
| S40.211 | Abrasion of right shoulder |
| S40.211A | Abrasion of right shoulder, initial encounter |
| S40.212 | Abrasion of left shoulder |
| S40.212A | Abrasion of left shoulder, initial encounter |
| S40.219 | Abrasion of unspecified shoulder |
| S40.219A | Abrasion of unspecified shoulder, initial encounter |
| S40.81 | Abrasion of upper arm |
| S40.811 | Abrasion of right upper arm |
| S40.811A | Abrasion of right upper arm, initial encounter |
| S40.812 | Abrasion of left upper arm |
| S40.812A | Abrasion of left upper arm, initial encounter |
| S40.819 | Abrasion of unspecified upper arm |
| S40.819A | Abrasion of unspecified upper arm, initial encounter |
| S50.31 | Abrasion of elbow |
| S50.311 | Abrasion of right elbow |
| S50.311A | Abrasion of right elbow, initial encounter |
| S50.312 | Abrasion of left elbow |
| S50.312A | Abrasion of left elbow, initial encounter |
| S50.319 | Abrasion of unspecified elbow |
| S50.319A | Abrasion of unspecified elbow, initial encounter |
| S50.81 | Abrasion of forearm |
| S50.811 | Abrasion of right forearm |
| S50.811A | Abrasion of right forearm, initial encounter |
| S50.812 | Abrasion of left forearm |
| S50.812A | Abrasion of left forearm, initial encounter |
| S50.819 | Abrasion of unspecified forearm |
| S50.819A | Abrasion of unspecified forearm, initial encounter |
| S60.31 | Abrasion of thumb |
| S60.311 | Abrasion of right thumb |
| S60.311A | Abrasion of right thumb, initial encounter |
| S60.312 | Abrasion of left thumb |
| S60.312A | Abrasion of left thumb, initial encounter |
| S60.319 | Abrasion of unspecified thumb |
| S60.319A | Abrasion of unspecified thumb, initial encounter |
| S60.41 | Abrasion of fingers |
| S60.410 | Abrasion of right index finger |
| S60.410A | Abrasion of right index finger, initial encounter |
| S60.411 | Abrasion of left index finger |
| S60.411A | Abrasion of left index finger, initial encounter |
| S60.412 | Abrasion of right middle finger |
| S60.412A | Abrasion of right middle finger, initial encounter |
| S60.413 | Abrasion of left middle finger |
| S60.413A | Abrasion of left middle finger, initial encounter |
| S60.414 | Abrasion of right ring finger |
| S60.414A | Abrasion of right ring finger, initial encounter |
| S60.415 | Abrasion of left ring finger |
| S60.415A | Abrasion of left ring finger, initial encounter |
| S60.416 | Abrasion of right little finger |
| S60.416A | Abrasion of right little finger, initial encounter |
| S60.417 | Abrasion of left little finger |
| S60.417A | Abrasion of left little finger, initial encounter |
| S60.418 | Abrasion of other finger |
| S60.418A | Abrasion of other finger, initial encounter |
| S60.419 | Abrasion of unspecified finger |
| S60.419A | Abrasion of unspecified finger, initial encounter |
| S60.51 | Abrasion of hand |
| S60.511 | Abrasion of right hand |
| S60.511A | Abrasion of right hand, initial encounter |
| S60.512 | Abrasion of left hand |
| S60.512A | Abrasion of left hand, initial encounter |
| S60.519 | Abrasion of unspecified hand |
| S60.519A | Abrasion of unspecified hand, initial encounter |
| S60.81 | Abrasion of wrist |
| S60.811 | Abrasion of right wrist |
| S60.811A | Abrasion of right wrist, initial encounter |
| S60.812 | Abrasion of left wrist |
| S60.812A | Abrasion of left wrist, initial encounter |
| S60.819 | Abrasion of unspecified wrist |
| S60.819A | Abrasion of unspecified wrist, initial encounter |
| S70.21 | Abrasion of hip |
| S70.211 | Abrasion, right hip |
| S70.211A | Abrasion, right hip, initial encounter |
| S70.212 | Abrasion, left hip |
| S70.212A | Abrasion, left hip, initial encounter |
| S70.219 | Abrasion, unspecified hip |
| S70.219A | Abrasion, unspecified hip, initial encounter |
| S70.31 | Abrasion of thigh |
| S70.311 | Abrasion, right thigh |
| S70.311A | Abrasion, right thigh, initial encounter |
| S70.312 | Abrasion, left thigh |
| S70.312A | Abrasion, left thigh, initial encounter |
| S70.319 | Abrasion, unspecified thigh |
| S70.319A | Abrasion, unspecified thigh, initial encounter |
| S80.21 | Abrasion of knee |
| S80.211 | Abrasion, right knee |
| S80.211A | Abrasion, right knee, initial encounter |
| S80.212 | Abrasion, left knee |
| S80.212A | Abrasion, left knee, initial encounter |
| S80.219 | Abrasion, unspecified knee |
| S80.219A | Abrasion, unspecified knee, initial encounter |
| S80.81 | Abrasion of lower leg |
| S80.811 | Abrasion, right lower leg |
| S80.811A | Abrasion, right lower leg, initial encounter |
| S80.812 | Abrasion, left lower leg |
| S80.812A | Abrasion, left lower leg, initial encounter |
| S80.819 | Abrasion, unspecified lower leg |
| S80.819A | Abrasion, unspecified lower leg, initial encounter |
| S90.41 | Abrasion of toe |
| S90.411 | Abrasion, right great toe |
| S90.411A | Abrasion, right great toe, initial encounter |
| S90.412 | Abrasion, left great toe |
| S90.412A | Abrasion, left great toe, initial encounter |
| S90.413 | Abrasion, unspecified great toe |
| S90.413A | Abrasion, unspecified great toe, initial encounter |
| S90.414 | Abrasion, right lesser toe(s) |
| S90.414A | Abrasion, right lesser toe(s), initial encounter |
| S90.415 | Abrasion, left lesser toe(s) |
| S90.415A | Abrasion, left lesser toe(s), initial encounter |
| S90.416 | Abrasion, unspecified lesser toe(s) |
| S90.416A | Abrasion, unspecified lesser toe(s), initial encounter |
| S90.51 | Abrasion of ankle |
| S90.511 | Abrasion, right ankle |
| S90.511A | Abrasion, right ankle, initial encounter |
| S90.512 | Abrasion, left ankle |
| S90.512A | Abrasion, left ankle, initial encounter |
| S90.519 | Abrasion, unspecified ankle |
| S90.519A | Abrasion, unspecified ankle, initial encounter |
| S90.81 | Abrasion of foot |
| S90.811 | Abrasion, right foot |
| S90.811A | Abrasion, right foot, initial encounter |
| S90.812 | Abrasion, left foot |
| S90.812A | Abrasion, left foot, initial encounter |
| S90.819 | Abrasion, unspecified foot |
| S90.819A | Abrasion, unspecified foot, initial encounter |
Formulary Reference Tool